StockComparison Logo
vs

RPTX vs ENGN

Comparison between Repare Therapeutics Inc (RPTX, Company) and enGene Holdings Inc (ENGN, Company).

Both RPTX and ENGN are from the Healthcare sector.

RPTX vs ENGN - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
RPTX
$114M
ENGN
$114M
Max Drawdown
RPTX
97.98%
Winner
ENGN
92.80%
Sharpe Ratio
Winner
RPTX
1.62
ENGN
0.40
5Y Beta
RPTX
N/A
ENGN
0.86
Industry
RPTX
Biotechnology
ENGN
Biotechnology
P/E Ratio
Winner
RPTX
-1.57
ENGN
-0.78
PEG Ratio
RPTX
N/A
ENGN
-0.02
Debt to Equity
RPTX
0.00%
ENGN
0.00%
Free Cash Flow Yield
Winner
RPTX
-61.58%
ENGN
-97.81%
P/B Ratio
RPTX
N/A
ENGN
0.44

RPTX vs ENGN - Historical Returns

Returns include dividend reinvestment.

1M
Winner
RPTX
+3.52%
ENGN
-1.07%
3M
Winner
RPTX
+48.04%
ENGN
+20.92%
6M
Winner
RPTX
+67.72%
ENGN
-82.58%
1Y
Winner
RPTX
+130.43%
ENGN
-51.32%
5Y(CAGR)
RPTX
-40.74%
ENGN
N/A
Max(CAGR)
Winner
RPTX
-35.42%
ENGN
-57.29%

RPTX vs ENGN - Annual Returns (2020 - 2026)

Returns include dividend reinvestment.

YearRPTXENGN
2026+3.11%-79.10%
2025+96.97%+27.90%
2024-82.03%-27.40%
2023-46.05%-53.85%
2022-32.77%N/A
2021-41.82%N/A
2020+11.36%N/A

RPTX vs ENGN Drawdown Comparison

The maximum drawdown for RPTX was -97.98%, occurring on Apr 10, 2025. This drawdown has not yet recovered.

The maximum drawdown for ENGN was -92.80%, occurring on May 12, 2026. This drawdown has not yet recovered.

The current RPTX drawdown is -94.04%. The current ENGN drawdown is -90.75%.

RankRPTXENGN
#1-97.98%
Jan 7, 2021 - Apr 10, 2025
-92.80%
Nov 1, 2023 - May 12, 2026
#2-34.68%
Jun 22, 2020 - Sep 16, 2020
N/A
#3-30.96%
Sep 17, 2020 - Dec 2, 2020
N/A
#4-16.08%
Dec 14, 2020 - Jan 7, 2021
N/A
#5-3.30%
Dec 8, 2020 - Dec 14, 2020
N/A

Correlation

Correlation between RPTX and ENGN is 0.60 which considered as a moderate positive correlation - the stocks show some tendency to move together.

0.60
-101

Select Stocks to Compare